Back to Research

Organization profile

BioMedPartners

BioMedPartners is a Basel-based venture capital firm that provides equity and mezzanine financing to early- and mid-stage healthcare and life science companies in the Alpine region. The firm focuses on biopharmaceuticals, medical devices, and diagnostics, leveraging a deep network and industry expertise to build innovative healthcare companies.

Basel, SwitzerlandFounded 2002

Overview

1. Executive Summary (Confidence: High)

BioMedPartners has established itself as one of the most prominent venture capital firms in the European healthcare sector, particularly within the Switzerland-Germany-Austria "Alpine Rim".[12] Since its inception in 2002, the firm has managed several funds, including the CHF 100 million BioMedInvest III, supporting more than 65 companies across the biotechnology and medical technology landscapes.[13] BioMedPartners typically takes a lead or co-lead investor role, providing not only capital but also active strategic guidance through board representation.[12] The firm is led by a team of industry veterans, including General Partners Dr. Markus Hosang and Dr. Michael Wacker, who bring extensive backgrounds in drug development, finance, and corporate leadership at firms like Roche.[12]

This is an extract of the full organization profile. To access the full company profile, .

Desktop only

Research is currently available on desktop only.

The Research module is designed for larger screens. Please reopen it on a desktop or laptop to use the screener, filters, detail pages, and admin tools.